Baar, Switzerland (ots/PRNewswire) - Healthcare Holding Switzerland AG, a leading provider of services and distributor of medical technology in Switzerland, has strengthened its portfolio with the acquisition of Schaublin Medica SA. Healthcare Holding Switzerland is managed by Winterberg Advisory GmbH. Healthcare Holding Switzerland AG has successfully completed the acquisition of Schaublin Medica SA. As part of a ...
Berlin/Stuttgart (ots) - - Immigrant-origin populations remain underrepresented in the national parliaments of Germany, the Netherlands, Spain, Switzerland, and the UK, with the Netherlands having the highest share (19%) and Spain the lowest (2%). - While representation has increased over the last decade ...
Strides Pharma International AG
Zurich (ots) - Globalance Bank, pioneer in sustainable investing is launching Globalance World, a world first in the form of a digital and interactive globe for sustainable investments. At www.globalanceworld.com, investors and other finance enthusiasts have free access to analyze and assess the future orientation and sustainability of currently over 6,000 listed ...
Salzburg/Melide(CH) (ots) - Swiss Biotech EvoBiotiX SA today announced a multi-year collaboration with Boehringer Ingelheim in the field of naturally derived EVs. A significant part of this program will fund research of the drug delivery potential of naturally derived EVs in the group of Prof. Meisner-Kober at the ...
Technische Universität München
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36260/ NEWS RELEASE New edition of the eGovernment MONITOR Digital administration: Corona is not ...
issuer: ams AG Tobelbader Strasse 30 A-8141 Premstaetten phone: +43 3136 500-0 FAX: +43 3136 500-931211 mail: investor@ams.com WWW: www.ams.com ISIN: AT0000A18XM4 indexes: stockmarkets: SIX Swiss Exchange language: ...
Basel (ots) - Versameb AG, a Swiss biopharmaceutical company, announced today the successful closing of a CHF 6.4 million Seed C financing round, bringing the total capital raised to date to CHF 11.8 million. Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs. The proceeds of this financing round will be used to expand ...
dpa Deutsche Presse-Agentur GmbH
QCAM Currency Asset Management AG
